Share data

Share this page

Share data

Listings in the U.S. and Europe

QIAGEN’s common shares have been registered and traded in the United States since 1996, listing on the New York Stock Exchange effective January 10, 2018, after trading on NASDAQ markets since the initial public offering (IPO). The shares have traded in Germany on the Frankfurt Stock Exchange since 1997, and the Prime Standard segment since its launch in 2003. Dual listing on NYSE and the Frankfurt exchange offers advantages for QIAGEN, our shareholders and employees since global presence increases the potential market opportunity and enhances liquidity. Unlike American Depositary Receipts (ADRs), QIAGEN shares provide equal corporate rights for all shareholders and can be traded on either exchange, in U.S. dollars or euros.

NASDAQ  2017 2016
Year-end price  $30.93 $28.02
High $35.37 $28.84
Low $27.43 $19.94
Average daily trading volume (in million shares) 0.95 1.0
Frankfurt Stock Exchange (XETRA) 2017 2016
Year-end price  €26.19 €26.68
High €31.46 €27.26
Low €25.71 €17.76
Average daily trading volume (in million shares) 0.44 0.4

Index Membership

QIAGEN is a constituent in various European, U.S. and global stock indices, some of which serve as benchmarks or investment universes for mutual funds and exchange traded funds. QIAGEN ranks as one of the leading components by market capitalization in Germany’s TecDAX index, which includes the 30 largest German technology companies not in the benchmark DAX index. QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. QIAGEN shares also are included in other stock market indexes such as the MSCI Europe, EMU and EAFE indexes.

Key share data  2017 2016
Total equity (in $ thousands) 2,540,996 2,607,096
Issued shares (in thousands)  230,829 239,707
Outstanding shares at December 31 (in thousands) 226,557 234,561
Weighted-average number of common shares outstanding - basic (in thousands) 228,074 234,800
Weighted-average number of common shares outstanding - diluted (in thousands) 233,009 238,993
Year-end market capitalization (in $ million) 7,002 6,572
Year-end market capitalization (in € million) 5,928 6,258